Fournillier; Anne

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fournillier; Anne.The latest application filed is for "composition comprising the polyprotein ns3/ns4 and the polypeptide ns5b of hcv, expression vectors including the corresponding nucleic sequences and their therapeutic use".

Company Profile

0.10.10

Fournillier; Anne - Lyons N/A FR
FOURNILLIER; Anne - Lyon FR
Fournillier; Anne - Villeurbanne FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic use Grant 8,541,004 - Fournillier , et al. September 24, 2	2013-09-24
Peptide compositions and their use in particular in the preparation of pharmaceutical compositions active against the hepatitis C virus Grant 8,293,528 - Inchauspe , et al. October 23, 2	2012-10-23
Composition Comprising The Polyprotein Ns3/ns4 And The Polypeptide Ns5b Of Hcv, Expression Vectors Including The Corresponding Nucleic Sequences And Their Therapeutic Use App 20120039938 - FOURNILLIER; Anne ; et al.	2012-02-16
Peptide compositions and their use against the hepatitis C virus Grant 8,080,525 - Fournillier , et al. December 20, 2	2011-12-20
Nucleic acid compositions and their use against the hepatitic C virus Grant 8,067,228 - Fournillier , et al. November 29, 2	2011-11-29
Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic use Grant 8,057,162 - Fournillier , et al. November 15, 2	2011-11-15
Novel peptide compositions and their use in particular in the preparation of pharmaceutical compositions active against the hepatitis C virus App 20110020398 - Inchauspe; Genevieve ; et al.	2011-01-27
Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic use Grant 7,695,960 - Inchauspe , et al. April 13, 2	2010-04-13
Composition Comprising The Polyprotein Ns3/ns4 And The Polypeptide Ns5b Of Hcv, Expression Vectors Including The Corresponding Nucleic Sequences And Their Therapeutic Use App 20100008941 - Fournillier; Anne ; et al.	2010-01-14
Anti-hepatitis C Virus Antibody And Uses Thereof App 20090104188 - Reiter; Christian ; et al.	2009-04-23
Novel Peptide Compositions and the Use Thereof, in Particular, in the Preparation of Active Pharmaceutical Compositions Against the Hepatitis C Virus App 20090087449 - Fournillier; Anne ; et al.	2009-04-02
Anti hepatitis C virus antibody and uses thereof Grant 7,507,408 - Reiter , et al. March 24, 2	2009-03-24
Novel Peptide Compositions and the Use Thereof, in Particular, in the Preparation of Active Pharmaceutical Compositions Against the Hepatitis C Virus App 20090075879 - Fournillier; Anne ; et al.	2009-03-19
Peptide compositions and their use against HCV Grant 7,393,831 - Fournillier , et al. July 1, 2	2008-07-01
Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic use App 20070269460 - Inchauspe; Genevieve ; et al.	2007-11-22
Novel peptide compositions and their use in particular in the preparation of pharmaceutical compositions active against the hepatitis C virus App 20070072176 - Inchauspe; Genevieve ; et al.	2007-03-29
Anti hepatitis C virus antibody and uses thereof App 20060153833 - Reiter; Christian ; et al.	2006-07-13
Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic use App 20060134065 - Fournillier; Anne	2006-06-22
Anti hepatitis C virus antibody and uses thereof Grant 6,951,646 - Reiter , et al. October 4, 2	2005-10-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.